This company listing is no longer active
Allena Pharmaceuticals Past Earnings Performance
Past criteria checks 0/6
Key information
-12.9%
Earnings growth rate
61.8%
EPS growth rate
Biotechs Industry Growth | -14.6% |
Revenue growth rate | n/a |
Return on equity | -1,157.5% |
Net Margin | n/a |
Last Earnings Update | 30 Jun 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Allena Pharmaceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 22 | 0 | -43 | 12 | 29 |
31 Mar 22 | 0 | -49 | 13 | 35 |
31 Dec 21 | 0 | -49 | 13 | 35 |
30 Sep 21 | 0 | -49 | 14 | 34 |
30 Jun 21 | 0 | -44 | 13 | 30 |
31 Mar 21 | 0 | -37 | 12 | 24 |
31 Dec 20 | 0 | -33 | 12 | 20 |
30 Sep 20 | 0 | -34 | 11 | 22 |
30 Jun 20 | 0 | -39 | 10 | 28 |
31 Mar 20 | 0 | -44 | 10 | 33 |
31 Dec 19 | 0 | -47 | 10 | 37 |
30 Sep 19 | 0 | -46 | 10 | 36 |
30 Jun 19 | 0 | -42 | 10 | 32 |
31 Mar 19 | 0 | -39 | 10 | 30 |
31 Dec 18 | 0 | -36 | 9 | 26 |
30 Sep 18 | 0 | -33 | 9 | 24 |
30 Jun 18 | 0 | -28 | 8 | 20 |
31 Mar 18 | 0 | -24 | 6 | 17 |
31 Dec 17 | 0 | -22 | 5 | 16 |
30 Sep 17 | 0 | -21 | 5 | 16 |
30 Jun 17 | 0 | -23 | 4 | 18 |
31 Mar 17 | 0 | -24 | 4 | 19 |
Quality Earnings: 0PJ is currently unprofitable.
Growing Profit Margin: 0PJ is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 0PJ is unprofitable, and losses have increased over the past 5 years at a rate of 12.9% per year.
Accelerating Growth: Unable to compare 0PJ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 0PJ is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-15.1%).
Return on Equity
High ROE: 0PJ has a negative Return on Equity (-1157.52%), as it is currently unprofitable.